Related Experiment Video

Updated: Jun 28, 2026

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
09:35

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

Intractable facial pain in advanced Parkinson's disease alleviated by subthalamic nucleus stimulation

K Samura, Y Miyagi, T Morioka

    Journal of Neurology, Neurosurgery, and Psychiatry
    |November 18, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery12:04

    Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery

    Published on: January 6, 2011

    Microelectrode Guided Implantation of Electrodes into the Subthalamic Nucleus of Rats for Long-term Deep Brain Stimulation10:52

    Microelectrode Guided Implantation of Electrodes into the Subthalamic Nucleus of Rats for Long-term Deep Brain Stimulation

    Published on: October 2, 2015

    Related Concept Videos

    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
    Parkinson's Disease: Overview01:15

    Parkinson's Disease: Overview

    Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...